EnBiotix: EnBiotix Closes $11M Pre-Merger Financing
BOSTON, Dec. 29, 2021 (GLOBE NEWSWIRE) - EnBiotix, Inc., a rare disease company currently focused on chronic respiratory disorders, today announced... Read MoreThe post EnBiotix Closes $11M Pre-Merger Financing appeared first on citybiz.
Read full article »
EnBiotix is a Massachusetts-based biotechnology firm that develops and commercializes therapies for the treatment of chronic respiratory disorders.
Read more